nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
225Ac-DOTATATE therapy in a case of metastatic pheochromocytoma
|
Peng, Dengsai |
|
|
49 |
10 |
p. 3596-3597 |
artikel |
2 |
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
|
Lam, Marnix |
|
|
49 |
10 |
p. 3340-3352 |
artikel |
3 |
Cervical lymph node staging in head and neck tumors: bridging the gap between humans and companion animals
|
Chiti, Lavinia Elena |
|
|
49 |
10 |
p. 3306-3308 |
artikel |
4 |
Construction and implementation of regional high-level PET alliance based on international consensus
|
Yang, Jianshe |
|
|
49 |
10 |
p. 3330-3331 |
artikel |
5 |
Correction to: An [18F]FDG‑PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients
|
Wallis, David |
|
|
49 |
10 |
p. 3598 |
artikel |
6 |
Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging
|
Tang, Yongxiang |
|
|
49 |
10 |
p. 3482-3491 |
artikel |
7 |
Diagnostic performance of total-body 18F-FDG PET/CT with fast 2-min acquisition for liver tumours: comparison with conventional PET/CT
|
Hu, Yan |
|
|
49 |
10 |
p. 3538-3546 |
artikel |
8 |
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
|
Fanti, Stefano |
|
|
49 |
10 |
p. 3328-3329 |
artikel |
9 |
EANM guideline on quality risk management for radiopharmaceuticals
|
Gillings, Nic |
|
|
49 |
10 |
p. 3353-3364 |
artikel |
10 |
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study
|
Clement, Dominique |
|
|
49 |
10 |
p. 3529-3537 |
artikel |
11 |
Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts
|
Lauri, Chiara |
|
|
49 |
10 |
p. 3430-3451 |
artikel |
12 |
FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial
|
de Koster, Elizabeth J. |
|
|
49 |
10 |
p. 3452-3469 |
artikel |
13 |
Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma
|
Unterrainer, Lena M. |
|
|
49 |
10 |
p. 3571-3580 |
artikel |
14 |
First experiences with dynamic renal [68Ga]Ga-DOTA PET/CT: a comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rate
|
Kersting, David |
|
|
49 |
10 |
p. 3373-3386 |
artikel |
15 |
First-time imaging of [89Zr]trastuzumab in breast cancer using a long axial field-of-view PET/CT scanner
|
Brouwers, Adrienne H. |
|
|
49 |
10 |
p. 3593-3595 |
artikel |
16 |
2022 follow-up: impact of the COVID-19 pandemic on nuclear medicine departments in Europe
|
Graham, Richard |
|
|
49 |
10 |
p. 3309-3315 |
artikel |
17 |
Freely available artificial intelligence for pelvic lymph node metastases in PSMA PET-CT that performs on par with nuclear medicine physicians
|
Trägårdh, Elin |
|
|
49 |
10 |
p. 3412-3418 |
artikel |
18 |
[68 Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease
|
Conen, Patrick |
|
|
49 |
10 |
p. 3365-3372 |
artikel |
19 |
Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
|
Lawal, Ismaheel O. |
|
|
49 |
10 |
p. 3581-3592 |
artikel |
20 |
Hossein Jadvar and Patrick M. Colletti (Eds): Nuclear Medicine: the Essentials
|
Mansi, Luigi |
|
|
49 |
10 |
p. 3305 |
artikel |
21 |
Intraoperative MET-receptor targeted fluorescent imaging and spectroscopy for lymph node detection in papillary thyroid cancer: novel diagnostic tools for more selective central lymph node compartment dissection
|
Jonker, Pascal K. C. |
|
|
49 |
10 |
p. 3557-3570 |
artikel |
22 |
Letter to the editor
|
Zogala, David |
|
|
49 |
10 |
p. 3334-3335 |
artikel |
23 |
[177Lu]Lu-DOTATATE peptide receptor radionuclide therapy–associated myeloid neoplasms: insights from the WHO pharmacovigilance database
|
Vigne, Jonathan |
|
|
49 |
10 |
p. 3332-3333 |
artikel |
24 |
Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [18F]FDG PET/CT study
|
Signore, Alberto |
|
|
49 |
10 |
p. 3419-3429 |
artikel |
25 |
PET/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival
|
Fiz, Francesco |
|
|
49 |
10 |
p. 3387-3400 |
artikel |
26 |
Quantification of amyloid PET for future clinical use: a state-of-the-art review
|
Pemberton, Hugh G. |
|
|
49 |
10 |
p. 3508-3528 |
artikel |
27 |
Quantitative assessment of myelin density using [11C]MeDAS PET in patients with multiple sclerosis: a first-in-human study
|
van der Weijden, Chris W. J. |
|
|
49 |
10 |
p. 3492-3507 |
artikel |
28 |
Response to letter to the editor
|
Kersting, David |
|
|
49 |
10 |
p. 3336-3339 |
artikel |
29 |
Second primary malignancy risk in thyroid cancer and matched patients with and without radioiodine therapy analysis from the observational health data sciences and informatics
|
Kim, Seok |
|
|
49 |
10 |
p. 3547-3556 |
artikel |
30 |
The “digital biopsy” in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT
|
Monaco, Lavinia |
|
|
49 |
10 |
p. 3401-3411 |
artikel |
31 |
The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer
|
Cao, Jingjia |
|
|
49 |
10 |
p. 3470-3481 |
artikel |
32 |
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging
|
Sollini, Martina |
|
|
49 |
10 |
p. 3320-3321 |
artikel |
33 |
To give or not to give? A critical appraisal of a clinical trial on radioiodine treatment
|
Tuncel, Murat |
|
|
49 |
10 |
p. 3316-3319 |
artikel |
34 |
Total-body [18F]FDG PET/CT scan has stepped into the arena: the faster, the better. Is it always true?
|
Filippi, Luca |
|
|
49 |
10 |
p. 3322-3327 |
artikel |